INTERNATIONAL PATENT: AMGEN INC. FILES APPLICATION FOR "COMPOSITIONS OF BISPECIFIC ANTIBODY CONSTRUCTS TO HUMAN DLL3 AND HUMAN CD3"

GENEVA, April 21 -- AMGEN INC. (One Amgen Center DriveThousand Oaks, California 91320-1799) filed a patent application (PCT/US2024/050541) for "COMPOSITIONS OF BISPECIFIC ANTIBODY CONSTRUCTS TO HUMAN DLL3 AND HUMAN CD3" on Oct 09, 2024. With publication no. WO/2025/080688, the details related to the patent application was published on Apr 17, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GUTIERREZ, Christian (c/o Amgen Inc., One Amgen Center DriveLaw Dept-Patent Operations, MS 28-5-AThousand Oaks, California 91320-1799), ELBARADEI, Ahmed (c/o Amgen Inc., One Amgen Center DriveLaw Dept-Pate...